Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 317

1.

A patient with type B insulin resistance syndrome, responsive to immune therapy.

Page KA, Dejardin S, Kahn CR, Kulkarni RN, Herold KC, Inzucchi SE.

Nat Clin Pract Endocrinol Metab. 2007 Dec;3(12):835-40.

PMID:
18026162
3.

Severe insulin resistance in a patient with type 1 diabetes and stiff-man syndrome treated with insulin lispro.

Hirsch IB, D'Alessio D, Eng L, Davis C, Lernmark A, Chait A.

Diabetes Res Clin Pract. 1998 Sep;41(3):197-202.

PMID:
9829349
4.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
5.

Type 1 diabetes developed in a type 2 diabetic patient with severe insulin resistance.

Suehiro T, Osaki F, Ikeda Y, Arii K, Nakayama F, Ota K, Hashimoto K.

Diabetes Res Clin Pract. 2005 Dec;70(3):298-302. Epub 2005 Jun 13.

PMID:
15955587
6.

Clinical efficacy of insulin-like growth factor-1 in a patient with autoantibodies to insulin receptors: a case report.

Yamamoto T, Sato T, Mori T, Yamakita T, Hasegawa T, Miyamoto M, Hosoi M, Ishii T, Yoshioka K, Tanaka S, Fujii S.

Diabetes Res Clin Pract. 2000 Jul;49(1):65-9.

PMID:
10808065
8.

Insulin lispro reduces insulin antibodies in a patient with type 2 diabetes with immunological insulin resistance.

Asai M, Kodera T, Ishizeki K, Uebori S, Kashiwaya T, Itoh H, Makino I.

Diabetes Res Clin Pract. 2003 Aug;61(2):89-92.

PMID:
12951276
9.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
10.

Fulminant Type 1 diabetes in a pregnant woman as an initial manifestation of the insulin autoimmune syndrome.

Kim HS, Lee TY, Kim EY, Choi JH, Kim SY, Hwang YC, Kang JH, Ahn KJ, Chung HY, Jeong IK.

Diabet Med. 2012 Oct;29(10):1335-8. doi: 10.1111/j.1464-5491.2012.03623.x.

PMID:
22356444
11.

Staged diabetes management according to individual patient insulin resistance and beta-cell function ameliorates glycaemic control in type 2 diabetes mellitus.

Choi SH, Hur KY, Kim DJ, Ahn CW, Kang ES, Cha BS, Lim SK, Huh KB, Lee HC.

Clin Endocrinol (Oxf). 2008 Oct;69(4):549-55. doi: 10.1111/j.1365-2265.2008.03199.x. Epub 2008 Jan 31.

PMID:
18248646
12.
13.

A patient with acute lymphoblastic leukaemia presenting with an extremely high level (21.0%) of HbA(1c).

Suzuki Y, Shichishima T, Yamashiro Y, Kimura H, Ishii R, Miyazaki K, Horie R, Moriya T, Hattori Y.

Ann Clin Biochem. 2011 Sep;48(Pt 5):474-7. doi: 10.1258/acb.2011.010121. Epub 2011 May 23.

PMID:
21606072
14.

Biphasic insulin aspart 30 treatment in patients with type 2 diabetes poorly controlled on prior diabetes treatment: results from the PRESENT study.

Sharma SK, Al-Mustafa M, Oh SJ, Azar ST, Shestakova M, Guler S, Vaz JA.

Curr Med Res Opin. 2008 Mar;24(3):645-52. doi: 10.1185/030079908X260952.

PMID:
18215338
15.

Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial.

Liebl A, Prager R, Binz K, Kaiser M, Bergenstal R, Gallwitz B; PREFER Study Group.

Diabetes Obes Metab. 2009 Jan;11(1):45-52. doi: 10.1111/j.1463-1326.2008.00915.x. Epub 2008 Jul 17.

PMID:
18643839
16.

The ratio of leptin to adiponectin can be used as an index of insulin resistance.

Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, Hayakawa N, Suzuki A, Takeda J, Horikawa Y, Itoh M.

Metabolism. 2008 Feb;57(2):268-73. doi: 10.1016/j.metabol.2007.09.011.

PMID:
18191059
18.

Low-dose metformin improves hyperglycaemia related to myotonic dystrophy.

Kouki T, Takasu N, Nakachi A, Tamanaha T, Komiya I, Tawata M.

Diabet Med. 2005 Mar;22(3):346-7.

PMID:
15717887
19.

Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.

Derosa G, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Cicero AF.

J Clin Pharm Ther. 2009 Feb;34(1):13-23. doi: 10.1111/j.1365-2710.2008.00984.x.

PMID:
19125899

Supplemental Content

Support Center